Talacen and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Talacen (acetaminophen; pentazocine hydrochloride), especially for people who are female, 60+ old, also take Forteo, and have Osteoporosis.

The phase IV clinical study analyzes which people have Rashes when taking Talacen. It is created by eHealthMe based on reports of 153 people who have side effects when taking Talacen from the FDA, and is updated regularly.

What is Talacen?

Talacen has active ingredients of acetaminophen; pentazocine hydrochloride. eHealthMe is studying from 157 Talacen users. Check the latest studies of Talacen.

What is Rashes?

Rashes (redness) is found to be associated with 3,715 drugs and 6,215 conditions by eHealthMe. Check the latest studies of Rashes.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

153 people reported to have side effects when taking Talacen.
Among them, 13 people (8.5%) have Rashes.

Among these 13 people:

What is the gender of people who have Rashes when taking Talacen? *

female: 84.62 %
male: 15.38 %

What is the age of people who have Rashes when taking Talacen? *

What are other drugs people take besides Talacen? *

What are other side effects people have besides Rashes? *

Fall: 9 people, 69.23%
Pathological Fracture (broken bone caused by disease): 8 people, 61.54%
Dental Fistula: 8 people, 61.54%
Gingival Disorder (gum disease): 8 people, 61.54%
Oral Infection: 8 people, 61.54%
Oral Disorder (mouth disease): 8 people, 61.54%
Oedema Peripheral (superficial swelling): 8 people, 61.54%
Oedema Mouth (swelling of mouth): 8 people, 61.54%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 8 people, 61.54%
Gingival Pain (gum pain): 8 people, 61.54%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 9 people, 69.23%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.69%
Nausea (feeling of having an urge to vomit): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Talacen and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Talacen:

Talacen (157 reports)

Rashes treatments and more:

Rashes (702,909 reports)

How severe was Rashes and when was it recovered:

Rashes in Talacen

Expand to all the drugs that have ingredients of acetaminophen; pentazocine hydrochloride:

Rashes and drugs with ingredients of acetaminophen; pentazocine hydrochloride

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Talacen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,715 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,215 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; pentazocine hydrochloride (the active ingredients of Talacen) and Talacen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.